13.3.1.4 Immunosuppressant
Click Here for Kent and Medway Health Economy National Tariff Excluded Drugs Manual -High Cost Drugs
  Baricitinib |
This High Cost Drug has been approved for the following indications: -Moderate to severe atopic dermatitis as per NICE Guidance below |
| For more information and NICE Guidance Click Here |
Baricitinib for treating moderate to severe atopic dermatitis NICE Guidance TA681 |
| Abrocitinib Tralokinumab Upadacitinib |
These High Cost Drugs have been approved for the following indications: - Moderate to severe atopic dermatitis as per NICE Guidance below |
| For more information and NICE Guidance Click Here | Abrocitinib, tralokinumab or upadacitinib for treating moderate to severe atopic dermatitis NICE Guidance TA814 |
| Deucravaticinib |
This High Cost Drug has been approved for the following indications: - treatment of moderate to severe plaque psoriasis as per NICE Guidance below |
| For more information and NICE Guidance Click Here | Deucravacitinib for treating moderate to severe plaque psoriasis NICE Guidance TA907 |
Pimecrolimus (Elidel) is Secondary Dermatology prescribing ONLY
| Pack |
|---|
| 100 gram |
| 30 gram |
| 60 gram |
- First Line Choice
- On Formulary
- Specialist Initiation Only
- Hospital Only
- KMPT Initiation Only